- Home
- PRTA vs SWIN Comparison
PRTA vs SWIN Comparison
Compare PRTA & SWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- SWIN
- Stock Information
- Founded
- PRTA 2012
- SWIN 2017
- Country
- PRTA Ireland
- SWIN Hong Kong
- Employees
- PRTA N/A
- SWIN N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- SWIN
- Sector
- PRTA Health Care
- SWIN
- Exchange
- PRTA Nasdaq
- SWIN Nasdaq
- Market Cap
- PRTA 472.1M
- SWIN 541.0M
- IPO Year
- PRTA N/A
- SWIN 2023
- Fundamental
- Price
- PRTA $9.86
- SWIN $2.93
- Analyst Decision
- PRTA Buy
- SWIN
- Analyst Count
- PRTA 10
- SWIN 0
- Target Price
- PRTA $12.29
- SWIN N/A
- AVG Volume (30 Days)
- PRTA 755.5K
- SWIN 660.1K
- Earning Date
- PRTA 11-11-2025
- SWIN 06-30-2025
- Dividend Yield
- PRTA N/A
- SWIN N/A
- EPS Growth
- PRTA N/A
- SWIN N/A
- EPS
- PRTA N/A
- SWIN N/A
- Revenue
- PRTA $10,341,000.00
- SWIN $3,316,000.00
- Revenue This Year
- PRTA N/A
- SWIN $29.79
- Revenue Next Year
- PRTA $602.32
- SWIN $54.60
- P/E Ratio
- PRTA N/A
- SWIN N/A
- Revenue Growth
- PRTA N/A
- SWIN N/A
- 52 Week Low
- PRTA $4.32
- SWIN $1.16
- 52 Week High
- PRTA $18.88
- SWIN $5.09
- Technical
- Relative Strength Index (RSI)
- PRTA 74.38
- SWIN 51.37
- Support Level
- PRTA $9.58
- SWIN $2.48
- Resistance Level
- PRTA $10.46
- SWIN $2.64
- Average True Range (ATR)
- PRTA 0.45
- SWIN 0.17
- MACD
- PRTA 0.11
- SWIN 0.07
- Stochastic Oscillator
- PRTA 75.41
- SWIN 92.98
About PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.
About SWIN Solowin Holdings
Solowin Holdings Ltd is an investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its secure one-stop electronic platform. It is engaged in providing securities-related services, investment advisory services, and asset management services to customers. The operations were organized into four reportable segments: Corporate Finance Services, Wealth Management Services, Asset Management Services and Virtual Assets. It derives maximum revenue from Wealth Management Services.